Literature DB >> 4911872

Mouse lysozyme production by a monocytoma: isolation and comparison with other lysozymes.

R J Riblet, L A Herzenberg.   

Abstract

A transplantable mouse tumor, GPC-11, produces large amounts of lysozyme. The tumor is a reticulum cell sarcoma, type A, and is a neoplasm of monocytes. The lysozyme was purified from mouse urine in quantities sufficient for structural analysis. Comparison of mouse lysozyme with lysozymes from; chicken egg white and patients with monocytic leukemia reveals similarities in size and electrophoretic mobility and, with human lysozyme, in functional properties; but considerable differences are found in antigenic characteristics and amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4911872     DOI: 10.1126/science.168.3939.1595

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  B-cell repertoire specific for an unfolded self-determinant of mouse lysozyme escape tolerance and dominantly participate in the autoantibody response.

Authors:  Yoshiyuki Tsujihata; Yousuke Mizukami; Tadashi Ueda; Takanori So; Taiji Imoto
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Purification and partial characterization of lysozyme from mouse small intestine.

Authors:  T L Peeters; G R Vantrappen
Journal:  Experientia       Date:  1976-09-15

3.  Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.

Authors:  P Ralph; M A Moore; K Nilsson
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

4.  Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme: implications in shaping of the T cell repertoire and autoimmunity.

Authors:  K D Moudgil; E E Sercarz
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

5.  In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.

Authors:  S Gordon; J Todd; Z A Cohn
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.